AMS 2025

Polish Researchers 3D Printing Novel Holdfast Devices for Atrial Procedure

RAPID

Share this Article

In ‘Evaluation of Local Tissue Reaction After the Application of a 3D Printed Novel Holdfast Device for Left Atrial Appendage Exclusion,’ researchers from Poland begin to experiment even further with 3D printed devices for assistance in cardiac procedures. Here, they experiment with the use of a new holdfast device meant ultimately to help eliminate chances of ischemic stroke. Employing the benefits of SLS 3D printing—with the capabilities to use versatile materials with even greater affordability—the researchers evaluated the results of their new device, implanting the devices in a group of 30 swine.

A macroscopic view of the left atrial appendage (LAA) closed with the holdfast device in group II (one tube coated with vascular implant). (a) The inner surface of the left atrium (LA) and (b) the intersection through the area of a holdfast device is shown. (a) Black arrows indicate the line of atrial wall adhesion placed between tubes of holdfast device. (b) The white arrow indicates the tube of holdfast device without and black arrow with a vascular implant. Red square indicates area showed in Fig. 8. MV mitral valve, LV left ventricle.

A finger-like extension of the left atrium, the left atrial appendage is a non-functional part of the left atrium. It happens to be a ‘prime cardiac site’ for thrombus formation, affecting patients with atrial fibrillation more commonly. And while treatment with antithrombotic treatment is widespread, here, the researchers investigate a more comprehensive approach in ‘obliterating the LAA.’ The use of holdfast devices, while effective, has been fraught with disadvantages, from issues with blood leakage to post-insertion adjustments, and lack of flexibility for modifications.

Microscopic view of the intersection through a holdfast device coated with a vascular implant used in group II. (a) Cross section through the device and the area between tubes of the holdfast device in group II. The the upper tube (*) was not coated with vascular implant and polyamide powder could be seen with an area of cicatrization. The lower tube (triangle) is coated with vascular implant and significant chronic inflammatory infiltrate is visible. (b) Higher magnification of the studied area with visible large number of giant cells.

“Considering the advantages and disadvantages of the available LAA closure devices, we designed a novel holdfast device for LAA obliteration devoid of these shortcomings,” stated the researchers.

The study allowed the researchers to further test biocompatibility, along with observing post-implementation issues. The device was created in partnership with the Technical University of Gdańsk, Poland, made up of two tubes connected with an elastic bow.

“The concept of operation for the device was based on the idea that the tubes would press the LAA base, which would lead to its closure and occlude the connection between the LAA and left atrium,” stated the researchers. “Moreover, the intention was that the device could be freely positioned around the LAA and could be easily adjusted after implantation.”

Their goal was to create a low stiffness spring with a ‘highly degressive characteristic of the device.’ They were able to do this through their choice of material and through shifting the bow crossection axis, with the devices implanted into the two swine groups. Safety and biocompatibility were noted, along with biofunctionality.

There were no perioperative deaths, and LAA occlusions occurred in all the swine.

“The foreign body reaction of the LAA holdfast device made of polyamide powder was found to be at a statistically insignificant level and was lower when compared to the polyester graft. Our device fulfills the criteria of biocompatibility to the highest degree, which makes it a suitable material for manufacturing LAA holdfast devices,” concluded the researchers. “This study proves that our technology may be applied for quick, innovative and individualized production of medical implants.“

3D printing has made huge strides in the medical realm, and definitely within the area of cardiac medicine, from cardiac patches to catheter devices, and even patient-specific heart valves models. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.

Column charts showing comparison of histological data between study groups.

[Source / Images: ‘Evaluation of Local Tissue Reaction After the Application of a 3D Printed Novel Holdfast Device for Left Atrial Appendage Exclusion’]

 

Share this Article


Recent News

3D Printing Webinar and Event Roundup: January 12, 2025

3D Printing News Briefs, January 11, 2025: Ceramics, Acrylated Vegetable Oil, & More



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

New AM Projects Get $2.1M Push from America Makes

America Makes has awarded $2.1 million to six new projects to tackle some of the biggest challenges in additive manufacturing (AM). The funding, provided by the U.S. Department of Defense...

Open Source Lab Instrument with 3D Printed Components Autonomously Monitors Embryos

There are several examples of 3D printed robots being used to help with aquatic research, but never anything quite like the autonomous LabEmbryoCam, developed over the past decade by the...

3D Printing News Briefs, December 28, 2024: Awards, Fast-Curing Silicone Ink, & More

We’re starting off with awards in today’s 3D Printing News Briefs, and then moving on to some interesting AM materials news. Read on for all the details! SME Recognizes Manufacturing...

Featured

ICON and Lennar to Build 100 3D Printed Homes for the Homeless

Additive construction startup ICON plans to build 100 3D-printed homes. Partnering with Austin, Texas-based homeless charity Mobile Loaves & Fishes, the initiative builds upon 17 3D-printed homes previously completed at...